XS
GILD icon

XR Securities’s Gilead Sciences GILD Stock Holding History

XR Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,500
Closed -$290K – 413
2023
Q1 		$290K Sell
3,500
-1,900
-35% -$157K 0.01% 321
2022
Q4 		$464K Sell
5,400
-4,700
-47% -$372K 0.05% 294
2022
Q3 		$9K Buy
+10,100
New +$637K ﹤0.01% 324
2020
Q4 		– Sell
-11,900
Closed -$6K – 449
2020
Q3 		$6K Sell
11,900
-9,000
-43% -$624K ﹤0.01% 263
2020
Q2 		$72K Buy
+20,900
New +$1.6M 0.01% 170
2020
Q1 		– Sell
-13,000
Closed -$4K – 240
2019
Q4 		$4K Buy
+13,000
New +$847K ﹤0.01% 219
2019
Q1 		– Sell
-27,800
Closed -$22K – 329
2018
Q4 		$22K Buy
27,800
+2,700
+11% +$189K 0.01% 256
2018
Q3 		$34K Buy
25,100
+10,100
+67% +$763K 0.01% 261
2018
Q2 		$6K Buy
+15,000
New +$1.06M ﹤0.01% 223

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XR Securities's GILD Position: Q2 2021 in Review

XR Securities sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 5,451 shares — an estimated $352K sold.

XR Securities first reported a position in GILD in Q2 2018 and held it in 8 quarters. The position peaked at $2.42M in Q4 2018. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • XR Securities reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • XR Securities sold 5,451 Gilead Sciences shares in Q2 2021, an estimated $352K.
  • XR Securities first reported a position in Gilead Sciences in Q2 2018 and held it in 8 quarters.
  • XR Securities's Gilead Sciences position peaked at $2.42M in Q4 2018.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on XR Securities's 13F filing for Q2 2021, filed 26 Jul 2021.